Nasopharyngeal cancer (NPC) arises in the nasopharynx mdash;the upper part of the throat located behind the nose and above ...

A research team from Southern Medical University has developed a machine learning-based gene model that predicts whether ...

Researchers in China have developed a powerful machine learning model that can help determine which patients with nasopharyngeal carcinoma (NPC) are likely to respond well to radiotherapy-a common ...

Nasopharyngeal carcinoma (NPC), a malignancy that develops in the upper section of the throat behind the nose, occurs in fewer than one person out of 100,000 worldwide each year. Locally advanced ...

GLOBOCAN 2022 reported more than 120,000 newly diagnosed NPC cases worldwide in 2022. In India, 6,519 new cases were recorded, with the highest age-adjusted incidence rates observed in the ...

Nasopharyngeal carcinoma (NPC) is a malignant tumor originating from the nasopharyngeal epithelium. Due to its concealed location and nonspecific early symptoms, most patients present with lymph ...

The data showed an NPC-specific mortality of 8.2 deaths per 1,000 person-years in the screened group versus 12.5 per 1,000 person-years in the unscreened group, representing a rate ratio of 0.70 ...

“As the next generation PD-1 inhibitor, Toripalimab has demonstrated superior outcomes for recurrent or metastatic nasopharyngeal carcinoma (RM-NPC) versus standard of care, thereby meeting a ...

Nasopharyngeal carcinoma (NPC) is a unique epithelial malignancy arising from the superior aspect of the pharyngeal mucosal space, associated with latent Epstein-Barr virus infection in most cases.